Len Cosentino serves as the Managing Director of NDI Healthcare Fund, where he plays a pivotal role in shaping the future of neurodevice technologies. With a robust background in venture capital, corporate finance, and business development, Len is dedicated to identifying and commercializing innovative solutions...
Len Cosentino serves as the Managing Director of NDI Healthcare Fund, where he plays a pivotal role in shaping the future of neurodevice technologies. With a robust background in venture capital, corporate finance, and business development, Len is dedicated to identifying and commercializing innovative solutions that enhance patient outcomes in the neurodevice sector. His expertise in FDA regulations and healthcare investments positions him as a key figure in navigating the complexities of bringing cutting-edge technologies to market.
At NDI Healthcare Fund, Len leads strategic initiatives that focus on the development and operational support of portfolio companies. His hands-on approach ensures that emerging neurodevice technologies not only meet regulatory standards but also align with market needs. One of his key projects includes collaborating with Checkpoint Surgical, Inc., a leader in handheld, intraoperative nerve stimulation solutions. This partnership exemplifies Len's commitment to advancing the science of nerve protection and repair, ultimately improving the quality of life for patients and healthcare providers alike.
Len’s entrepreneurial spirit drives him to seek out joint ventures and licensing opportunities that can further propel innovative neurodevice solutions. His extensive network and deep understanding of the healthcare landscape enable him to forge valuable connections that facilitate growth and commercialization. Through his leadership at NDI Healthcare Fund, Len Cosentino is not only influencing the trajectory of neurodevice innovation but also ensuring that the advancements translate into tangible benefits for patients and the medical community.
